Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest National Institute on Drug Abuse Stories

2011-03-23 16:19:00

Cannabis Should Be Subjected to the Standards of Federal Regulators Rather than to Voters' Whims at the Ballot Box CHEVY CHASE, Md., March 23, 2011 /PRNewswire-USNewswire/ -- Citing the dangers of marijuana, the lack of clinical research on a controlled substance with a high potential for abuse, and the physician's oath to "first, do no harm," the American Society of Addiction Medicine (ASAM) today issued a white paper recommending a halt to using the weed as a medicine in states where it...

2011-03-09 18:09:00

WASHINGTON, March 9, 2011 /PRNewswire-USNewswire/ -- On Monday, March 7, Professor Lyle Craker, Director of the Medicinal Plant Program at the University of Massachusetts-Amherst, filed the final brief in his ten-year fight to persuade the Drug Enforcement Administration to allow him to grow marijuana for medical research. Craker is represented by the American Civil Liberties Union (ACLU) and law firm Jenner & Block. Craker is seeking a license to grow marijuana under contract to the...

2011-03-08 04:00:00

WHITE PLAINS, N.Y., March 8, 2011 /PRNewswire/ -- A new study has found that Botvin's LifeSkills Training (LST) program is the top evidence-based drug abuse prevention program in the United States, based on use by elementary schools. According to the study, more elementary schools in the US choose to use the LST program over all other evidence-based prevention programs. Based on the study, among the evidence-based curricula, LST was the program used most frequently and by the most...

2011-03-02 19:42:23

A new mouse model closely resembles how the human body reacts to early HIV infection and is shedding light on nerve cell damage related to the disease, according to researchers funded by the National Institutes of Health. The study in today's Journal of Neuroscience demonstrates that HIV infection of the nervous system leads to inflammatory responses, changes in brain cells, and damage to neurons. This is the first study to show such neuronal loss during initial stages of HIV infection in a...

2011-02-23 17:15:49

Special issue of Neuron examines the new neuroscience of substance abuse Addiction is a brain disease that destroys lives, devastates families and tears at the very fabric of society. Effective prevention and treatment of addiction requires a clear understanding of the complex brain mechanisms that underlie addictive behaviors, and research has provided a fascinating view of how substance abuse hijacks neuronal circuits involved in reward and motivation and causes profound and persistent...

2011-02-22 06:00:00

SEATTLE, Feb. 22, 2011 /PRNewswire/ -- Omeros Corporation (Nasdaq: OMER) today announced that its exclusive license to phosphodiesterase 7 (PDE7) inhibitors from Daiichi Sankyo Co., Ltd. has been amended to include addiction and compulsive disorders in the field of use. Omeros' PDE7 program was founded on the Company's discovery of a previously unknown link between PDE7 and any movement disorder, such as Parkinson's disease. Omeros believes that it also is the first to link PDE7 to any...

2011-02-15 08:52:00

SANTA CRUZ, Calif., Feb. 15, 2011 /PRNewswire-USNewswire/ -- Today the journal Addiction published online the results of a neuroscience study finding no evidence of impaired cognitive performance in users of Ecstasy, the street name for the chemical known as MDMA. The study, conducted by researchers at Harvard-affiliated McLean Hospital, improves on earlier studies in several ways. It used subjects who used few or no other drugs or alcohol, compared those subjects to others from the same...

a6826f93431f3e53b6202af16315351d1
2011-02-15 07:45:00

Ecstasy use does not impair a person's cognitive function or diminish their mental ability, according to a new study published Tuesday in the journal Addiction. The National Institute on Drug Abuse (NIDA) funded study compared 52 users of Ecstasy, also known as methylenedioxymethamphetamine or MDMA, with 59 non-users. They found that using the drug, which the NIDA says "is chemically similar to the stimulant methamphetamine and the hallucinogen mescaline" and "produces feelings of increased...

2011-02-03 01:32:19

UT Southwestern Medical Center psychiatry researchers are leading the Texas arm of a national network that conducts clinical trials aimed at finding effective treatments for drug addiction. More than 100 community treatment providers and academic medical centers throughout the country are funded in part through the National Institute on Drug Abuse's Clinical Trials Network (CTN). The Texas component includes partnerships between academic and community treatment providers in Dallas, El Paso,...

2011-01-18 22:34:46

Time-lapse technique can show cellular changes related to problems like addiction and brain tumors Changes within deep regions of the brain can now be visualized at the cellular level, based on research on mice, which was funded by the National Institutes of Health. Published Sunday in Nature Medicine, the study used a groundbreaking technique to explore cellular-level changes over a period of weeks within deep brain regions, providing a level of detail not possible with previously available...